These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 18616510)

  • 41. Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury.
    Hwang YC; Shaw S; Kaneko M; Redd H; Marrero MB; Ramasamy R
    FASEB J; 2005 May; 19(7):795-7. PubMed ID: 15746188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Piperlongumine induces apoptotic and autophagic death of the primary myeloid leukemia cells from patients via activation of ROS-p38/JNK pathways.
    Xiong XX; Liu JM; Qiu XY; Pan F; Yu SB; Chen XQ
    Acta Pharmacol Sin; 2015 Mar; 36(3):362-74. PubMed ID: 25619389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bim and Mcl-1 exert key roles in regulating JAK2V617F cell survival.
    Rubert J; Qian Z; Andraos R; Guthy DA; Radimerski T
    BMC Cancer; 2011 Jan; 11():24. PubMed ID: 21247487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia.
    Eriksson A; Kalushkova A; Jarvius M; Hilhorst R; Rickardson L; Kultima HG; de Wijn R; Hovestad L; Fryknäs M; Öberg F; Larsson R; Parrow V; Höglund M
    Biochem Pharmacol; 2014 Jan; 87(2):284-91. PubMed ID: 24200998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism.
    Liu J; Joha S; Idziorek T; Corm S; Hetuin D; Philippe N; Preudhomme C; Quesnel B
    Leukemia; 2008 Apr; 22(4):791-9. PubMed ID: 18216868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production.
    Versteeg HH; Spek CA; Slofstra SH; Diks SH; Richel DJ; Peppelenbosch MP
    Circ Res; 2004 Apr; 94(8):1032-40. PubMed ID: 15016732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Purvalanol A induces apoptosis and downregulation of antiapoptotic proteins through abrogation of phosphorylation of JAK2/STAT3 and RNA polymerase II.
    Iizuka D; Ogura A; Kuwabara M; Inanami O
    Anticancer Drugs; 2008 Jul; 19(6):565-72. PubMed ID: 18525315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
    Liu Y; Wang L; Wu Y; Lv C; Li X; Cao X; Yang M; Feng D; Luo Z
    Toxicology; 2013 Feb; 304():120-31. PubMed ID: 23313376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TAT-mediated delivery of neuroglobin attenuates apoptosis induced by oxygen-glucose deprivation via the Jak2/Stat3 pathway in vitro.
    Lin Y; Cai B; Xue XH; Fang L; Wu ZY; Wang N
    Neurol Res; 2015 Jun; 37(6):531-8. PubMed ID: 25023896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MSK1 activation in acute myeloid leukemia cells with FLT3 mutations.
    Odgerel T; Kikuchi J; Wada T; Shimizu R; Kano Y; Furukawa Y
    Leukemia; 2010 May; 24(5):1087-90. PubMed ID: 20357825
    [No Abstract]   [Full Text] [Related]  

  • 51. JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation.
    Oku S; Takenaka K; Kuriyama T; Shide K; Kumano T; Kikushige Y; Urata S; Yamauchi T; Iwamoto C; Shimoda HK; Miyamoto T; Nagafuji K; Kishimoto J; Shimoda K; Akashi K
    Br J Haematol; 2010 Aug; 150(3):334-44. PubMed ID: 20553273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AZ960, a novel Jak2 inhibitor, induces growth arrest and apoptosis in adult T-cell leukemia cells.
    Yang J; Ikezoe T; Nishioka C; Furihata M; Yokoyama A
    Mol Cancer Ther; 2010 Dec; 9(12):3386-95. PubMed ID: 21159615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Indole-3-carbinol induces apoptosis of chronic myelogenous leukemia cells through suppression of STAT5 and Akt signaling pathways.
    Safa M; Jafari L; Alikarami F; Manafi Shabestari R; Kazemi A
    Tumour Biol; 2017 Jun; 39(6):1010428317705768. PubMed ID: 28631564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo.
    Yang J; Ikezoe T; Nishioka C; Nobumoto A; Yokoyama A
    Int J Cancer; 2013 Oct; 133(8):1967-81. PubMed ID: 23564444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proliferation and survival signaling from both Jak2-V617F and Lyn involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 cell line newly established from acute myeloid leukemia transformed from polycythemia vera.
    Nagao T; Kurosu T; Umezawa Y; Nogami A; Oshikawa G; Tohda S; Yamamoto M; Miura O
    PLoS One; 2014; 9(1):e84746. PubMed ID: 24404189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abivertinib, a novel BTK inhibitor: Anti-Leukemia effects and synergistic efficacy with homoharringtonine in acute myeloid leukemia.
    Huang S; Pan J; Jin J; Li C; Li X; Huang J; Huang X; Yan X; Li F; Yu M; Hu C; Jin J; Xu Y; Ling Q; Ye W; Wang Y; Jin J
    Cancer Lett; 2019 Oct; 461():132-143. PubMed ID: 31310800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. β-Catenin and AKT are promising targets for combination therapy in acute myeloid leukemia.
    Wang L; You LS; Ni WM; Ma QL; Tong Y; Mao LP; Qian JJ; Jin J
    Leuk Res; 2013 Oct; 37(10):1329-40. PubMed ID: 23867056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms.
    Grimwade LF; Happerfield L; Tristram C; McIntosh G; Rees M; Bench AJ; Boyd EM; Hall M; Quinn A; Piggott N; Scorer P; Scott MA; Erber WN
    Br J Haematol; 2009 Nov; 147(4):495-506. PubMed ID: 19747364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SOCS2: inhibitor of JAK2V617F-mediated signal transduction.
    Quentmeier H; Geffers R; Jost E; Macleod RA; Nagel S; Röhrs S; Romani J; Scherr M; Zaborski M; Drexler HG
    Leukemia; 2008 Dec; 22(12):2169-75. PubMed ID: 18769447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cytotoxicity of homoharringtonine on leukemic stem-like cells in AML cell line KG-1].
    Shen JP; Yang H; Ni WM; Qian WB
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 41(5):485-90. PubMed ID: 23086639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.